| APUD | Amine precursor uptake and decarboxylation |
| CgA | Chromogranin A |
| CHD | Carcinoid heart disease |
| Cr | Creatinine |
| CT | Computed tomography |
| CRP | C-reactive protein |
| eGFR | Estimated glomerular filtration rate |
| ENETS | European neuroendocrine tumor society |
| EUS-FNA | Endoscopic ultrasound with fine-needle aspiration |
| EUS-FNB | Endoscopic ultrasound with fine-needle biopsy |
| FAST | Focused assessment with sonography in trauma |
| 68Ga-DOTA-NOC | Gallium-68-DOTA-Nal3-octreotide |
| 68Ga-DOTA-TATE | Gallium-68-DOTA-Tyr3-octreotate |
| 68Ga-DOTA-TOC | Gallium-68-DOTA-Tyr3-octreotide |
| GEP-NEN | Gastroenteropancreatic neuroendocrine neoplasm |
| GEP-NET | Gastroenteropancreatic neuroendocrine tumor |
| HGT | Hemo-glucose test |
| 5-HIAA | 5-hydroxyindoleacetic acid |
| 5-HT | Serotonin |
| INSM1 | Insulinoma-associated protein 1 |
| JNETS | Japanese neuroendocrine tumor society |
| MEN-1 | Multiple-endocrine neoplasia 1 |
| MiNEN | Mixed neuroendocrine–non-neuroendocrine neoplasm |
| MRI | Magnetic-resonance imaging |
| NF-Pan-NET | Non-functional pancreatic neuroendocrine tumor |
| NEC | Neuroendocrine carcinoma |
| NEN | Neuroendocrine neoplasm |
| NET | Neuroendocrine tumor |
| NSE | Neuron-specific enolase |
| Pan-NET | Pancreatic neuroendocrine tumor |
| PAD | Peripheral artery disease |
| PET | Positive-emission tomography |
| PPi | Proton pomp inhibitor |
| PPRT | Peptide receptor radionuclide therapy |
| SaO2 | Oxygen saturation |
| SSA | Somatostatin analog |
| SSTR | Somatostatin receptor |
| VHL | von Hippel–Lindau syndrome |
| VIP | Vaso-active intestinal peptide |
| WHO | World Health Organization |